Genetic Treatment Extends Fruit Fly Lifespan and Prevents Alzheimer’s Damage | Nutrition Fit



Summary: Modifying the levels of two different proteins active in two different brain cells extended the life of fruit flies by 7-9%. The treatment also reduced the buildup of Alzheimer’s related amyloid plaques within the brain.

Source: UCL

Modifying brain cell activity can extend the lifespan of fruit flies while also preventing the damage characteristic of Alzheimer’s disease, finds a new study led by UCL researchers.

The researchers found that by modifying the levels of two different proteins that are active in two different types of brain cells, they could extend fruit fly lifespans by around 7-9% (close to an extra week), they report in PNAS.

The treatments also reduced the buildup of amyloid, the harmful brain proteins characteristic of Alzheimer’s disease, in flies that have been bred as models for researching the disease.

The research group at the UCL Institute of Healthy Ageing has previously found other ways to extend fruit fly lifespan by over 10%, or even by 48% when using a combination of three drugs (which are all approved for use in people for different medical conditions).* While smaller than the lifespan extensions in some other fruit fly studies, this latest research is notable for extending lifespan by only targeting one type of cell in the nervous system, rather than cells across the whole body. They have yet to investigate whether combining their new treatments with other methods could yield additional benefits.

In the latest study, the researchers were investigating ways to modify the insulin growth factor signalling pathway, which is being increasingly studied for its key role in the ageing process.

This shows neurons in a fly brain
In aged brains and in Alzheimer’s disease, a variety of proteins damage brain cells by accumulating into aggregates. Fruit fly brains can be engineered to produce some of these damaging proteins, as seen with yellow (p62/REF2P) and magenta (poly-ubiquitin) aggregates in this brain from a fly genetically engineered to produce the Alzheimer’s-associate amyloid-beta protein. The researchers in this paper identified a gene that protects against this damaging protein accumulation. Credit: Nathan Woodling

Co-lead author Dr Nathan Woodling (UCL Institute of Health Ageing, UCL Biosciences) said: “Insulin is very important to development, but it appears that we may have too much of it late in life. Insulin signalling likely developed through evolution due to its benefits early in life, in spite of its detrimental effects later in life.”

“Here, we were seeking to understand how ageing predisposes the brain to dementia, in order to one day find new ways to help us live well for longer.”

The team identified several new factors involved in insulin signalling that contribute to ageing in the fruit fly (Drosophila) brain, and that found that two proteins – which are comparable to proteins in human brains – act on two different cell types as part of the ageing process. The scientists developed two new genetic treatments modifying the quantities of proteins which control whether a gene is active or silent, one of which was targeted at neurons in fruit flies and the other of which targeted glial cells.

After finding that the treatments extended fruit fly lifespans, they tested the neuron treatment in flies that had been bred to produce amyloid, the protein believed to cause Alzheimer’s disease, and found that the treatment protected these flies’ brains from amyloid buildup while preserving behavioural function.

Co-lead author Dr Ekin Bolukbasi (UCL Institute of Health Ageing, UCL Biosciences) said: “Our work opens up new strategic directions for dementia therapeutics; specifically, future efforts will need to carefully consider how any potential treatment acts on the full diversity of cells in our brains. Treatments using emerging medical technology to target specific cell types may hold potential to extend how long we live in good health.”

Funding: The study was funded by Wellcome, the Max Planck Society, and the Alzheimer’s Society.

About this genetics research news

Source: UCL
Contact: Chris Lane – UCL
Image: The image is credited to Nathan Woodling

Original Research: Open access.
Cell type-specific modulation of healthspan by Forkhead family transcription factors in the nervous system” by Nathan Woodling et al. PNAS


See also

This shows a happy woman with a heart balloon

Cell type-specific modulation of healthspan by Forkhead family transcription factors in the nervous system

Reduced activity of insulin/insulin-like growth factor signaling (IIS) increases healthy lifespan among diverse animal species. Downstream of IIS, multiple evolutionarily conserved transcription factors (TFs) are required; however, distinct TFs are likely responsible for these effects in different tissues.

Here we have asked which TFs can extend healthy lifespan within distinct cell types of the adult nervous system in Drosophila. Starting from published single-cell transcriptomic data, we report that forkhead (FKH) is endogenously expressed in neurons, whereas forkhead-box-O (FOXO) is expressed in glial cells.

Accordingly, we find that neuronal FKH and glial FOXO exert independent prolongevity effects. We have further explored the role of neuronal FKH in a model of Alzheimer’s disease-associated neuronal dysfunction, where we find that increased neuronal FKH preserves behavioral function and reduces ubiquitinated protein aggregation. Finally, using transcriptomic profiling, we identify Atg17, a member of the Atg1 autophagy initiation family, as one FKH-dependent target whose neuronal overexpression is sufficient to extend healthy lifespan.

Taken together, our results underscore the importance of cell type-specific mapping of TF activity to preserve healthy function with age.


Source link